Summary
The morphine (75 mg/kg i.p.) induced stimulation of motor activity in mice was significantly suppressed by small doses of central catecholamine (CA) receptor agonists, apomorphine (0.2 mg/kg) and clonidine (0.05 mg/kg). In the same dose, and at the same time interval as the behavioural stimulation was obtained, morphine did not significantly affect thein vivo rate of tyrosine hydroxylation in two dopamine (DA)-rich mouse brain regions, the corpus striatum and the limbic system, or in the noradrenaline (NA)-rich, but DA-poor hemispheres, measured as the Dopa-accumulation during 30 min after inhibition of aromatic amino-acid decarboxylase by 3-hydroxybenzylhydrazine (NSD 1015) 150 mg/kg. The apomorphine induced reduction in Dopa accumulation in the DA-rich brain regions was not significantly affected by morphine. The disappearance rate of brain NA after inhibition of tyrosine hydroxylase byα-methyltyrosine methylester (250 mg/kg), the utilization of NA, was accelerated by morphine, whereas that of DA was not affected. Clonidine (0.05 mg/kg) retarded selectively brain NA utilization, and also suppressed the morphine-induced increase in NA utilization.
In conclusion, morphine's stimulation of motor activity in mice, an effect which previously has been found to be correlated with its dependence producing action, could be inhibited by apomorphine or clonidine in small doses which inhibit brain DA- and NA-neurons, respectively. Thus, we have now shown the psychomotor stimulation by two euphoriant and dependenceproducing drugs, ethanol and morphine, to be suppressed by CA “autoreceptor” activation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agbajanian, G. K., Bunney, B. S. Dopamine “autoreceptors”: Pharmacological characterization by microiontophoretic single cell recording studies. Naunyn-Schmiedeberg's Arch. Pharmacol.297, 1–7 (1977).
Ahlenlus, S., Carlsson, A., Engel, J., Svensson, T. H., Södersten, P. Antagonism byα-ethyltyrosine of the ethanol-induced stimulation and euphoria in man. Clin. Pharmacol. Ther.14, 586–591 (1973).
Andén, N.-E., Corrodi, H., Fuxe, K. Turnover studies using synthesis inhibition. In: Metabolism of Amines in the Brain (Hooper, G., ed.), pp. 38–47. London: MacMillan. 1969.
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C., Svensson, T. H. Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci.9, 513–523 (1970).
Andén, N.-E., Grabowska, M. Synthesis and disappearance of central noradrenaline and dopamine: Regulation via nerve impulses and receptor activity. In: Chemical Tools in Catecholamine Research, part II. Regulation of Catecholamines Turnover (Almgren, O., Carlsson, A., Engel, J., eds.). Amsterdam: North Holland Publishing Co. 1975.
Andén, N.-E., Grabowska, M., Strömbom, U. Differentα-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol.292, 43–52 (1976).
Andén, N.-E., Strömbom, U., Svensson, T. H. Dopamine and noradrenaline receptor stimulation: Reversal of reserpine-induced suppression of motor activity. Psychopharmacologia (Berl.)29, 289–298 (1973).
Atack, C. V. The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay. Brit. J. Pharmacol.48, 267–284 (1973).
Atack, C. V., Magnusson, T. Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single, strong cation exchange column by means of mineral acidorganic solvent mixtures. J. Pharm. Pharmacol.22, 625–627 (1970).
Bertler, Å., Carlsson, A., Rosengren, E. A method for the fluorimetric determination of adrenaline and noradrenaline in tissue. Acta physiol. scand.44, 273–292 (1958).
Brase, D. H., Loh, H. H., Way, E. L. Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains. J. Pharmacol. exp. Ther.201, 368–374 (1977).
Carlsson, A. Receptor-mediated control of dopamine metabolism. In: Pre-and Postsynaptic Receptors (Usdin, E., Bunney, W. E., eds.), pp. 49–65. New York: Marcel Dekker. 1975.
Carlsson, A., Davis, J. N., Kehr, W., Lindqvist, M., Atack, C. Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brainin vivo using in inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch. Pharmacol.275, 153–168 (1972).
Carlsson, A., Engel, J., Strömbom, U., Svensson, T. H., Waldeck, B. Suppression by dopamine-agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis. Naunyn-Schmiedeberg's Arch. Pharmacol.283, 117–128 (1974).
Carlsson, A., Engel, J., Svensson, T. H. Inhibition of ethanol-induced excitation in mice and rats byα-methyl-p-tyrosine. Psychopharmacologia (Berl.)26, 307–312 (1972).
Carlsson, A., Lindqvist, M. Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo. J. Pharm. Pharmacol.25, 437–440 (1973).
Carlsson, A., Magnusson, T., Svensson, T. H., Waldeck, B. Effect of ethanol on the metabolism of brain catecholamines. Psychopharmacologia (Berl.)30, 27–36 (1973).
Carrol, B. J., Sharp, P. T. Monoamine mediation of the morphine-induced activation of mice. Brit. J. Pharmac.46, 124–139 (1972).
Eddy, N. B.: Morphine. Action on the nervous system. In: The Pharmacology of the Opium Alkaloids (Krueger, H., Eddy, N. B., Sumwalt, M., eds.), pp. 1–76. Washington: U.S. Public Health Service No. 165. 1941.
Eidelberg, E., Erspamer, R. Dopaminergic mechanisms of opiate actions in brain. J. Pharmacol. exp. Ther.192, 50–57 (1975).
Engström, G., Svensson, T. H., Waldeck, B. Thyroxine and brain catecholamines: Increased transmitter synthesis and increased receptor sensitivity. Brain Res.77, 471–483 (1974).
Goldstein, A., Sheehan, P. Tolerance of opioid narcotics. I. Tolerance to the “running fit” caused by levorphanol in the mouse. J. Pharmacol. exp. Ther.169, 175–184 (1969).
Gomes, C., Svensson, T. H., Trolin, G. Effects of morphine on central catecholamine turnover, blood pressure and heart rate in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol.294, 141–147 (1976).
Gunne, L. M., Jonsson, J., Fuxe, K. Effects of morphine intoxication on brain catecholamine neurons. Europ. J. Pharmacol.5, 338–342 (1969).
Hanson, L. C. F. Evidence that the central action of amphetamine is mediated via catecholamines. Psychopharmacologia (Berl.)9, 78–80 (1966).
Hollinger, M. Effect of reserpine,α-methyl-p-tyrosine, p-chlorophenylalanine and pargyline on levorphanol-induced running activity in mice. Arch. int. Pharmacodyn.179, 419–424 (1969).
Jönsson, L. E., Gunne, L. M., Änggård, E. Effect ofα-methyltyrosine in amphetamine-dependent subjects. Pharmacol. Clin.2, 27–29 (1969).
Kehr, W., Carlsson, A., Lindqvist, M. A method for the determination of 3, 4-dihydroxyphenylalanine (Dopa) in brain. Naunyn-Schmiedeberg's Arch. Pharmacol.274, 273–280 (1972).
Korf, J., Bunney, B. S., Aghajanian, G. K. Noradrenergic neurons: Morphine inhibition of spontaneous activity. European J. Pharmacol.25, 165–169 (1974).
Kuschinsky, K., Hornykiewicz, O. Effects of morphine on striatal dopamine metabolism: Possible mechanism of its opposite effect on locomotor activity in rats and mice. European J. Pharmacol.26, 41–50 (1974).
Maj, J., Sowinska, H., Kapturkiewics, Z., Sarnek, J. The effect of L-DOPA and (+)-amphetamine on the locomotor activity after pimozide and phenoxybenzamine. J. Pharm. Pharmac.24, 412–414 (1972).
Marshall, I., Smith, C. B. Acute and chronic morphine treatment and the hydroxylation of (1-14C)-l-tyrosine in the mouse brain. Brit. J. Pharmacol.50, 428–430 (1974).
Montel, H., Starke, K., Taube, H. D. Influence of morphine and naloxone on the release of noradrenaline from rat cerebellar cortex slices. Naunyn-Schmiedeberg's Arch. Pharmacol.288, 427–433 (1975).
Pohorecky, L. A., Jaffe, L. S. Noradrenergic involvement in the acute effects of ethanol. Res. Commun. Chem. Path. Pharmacol.12, 433–447 (1975).
Randrup, A., Munkvad, I. Role of catecholamines in the amphetamine excitatory response. Nature (Lond.)211, 540 (1966).
Rolinski, Z., Scheel-Kriiger, J. The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats. Acta pharmacol. et toxicol.33, 385–399 (1973).
Scheel-Kriiger, J., Golembioivska, K., Mogilnicka, E. Evidence for increased apomorphine-sensitive dopaminergic effects after acute treatment with morphine. Psychopharmacology53, 55–63 (1977).
Shuster, H., Hannam, R., Boyle, W. A simple method for producing tolerance to dihydromorphinone in mice. J. Pharmacol. exp. Ther.140, 149–154 (1963).
Smith, C. B., Sheldon, M. I., Bednarczyk, J. H., Villarreal, J. E. Morphineinduced increases in the incorporation of3H-tyrosine into14C-dopamine and14C-norepinephrine in the mouse brain: Antagonism by naloxone and tolerance. J. Pharmacol. exp. Ther.180, 547–557 (1972).
Smith, C. B., Villarreal, J. E., Bednarczyk, J. H., Sheldon, M. I. Tolerance to morphine-induced increases in14C-catecholamine synthesis in mouse brain. Science (Washington)170, 1106–1108 (1970).
Starke, K., Mantel, H. Involvement ofα-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurons. Neuropharmacology12, 1073–1080 (1973).
Strömbom, U.: On the functional role of pre- and postsynaptic catecholamine receptors in brain. Acta physiol. scand. Suppl.431 (1975).
Strömbom, U. Catecholamine receptor agonists: Effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn-Schmiedeberg's Arch. Pharmacol.292, 167–196 (1976).
Strömbom, U., Svensson, T. H., Carlsson, A. Antagonism of ethanol's central stimulation in mice by small doses of catecholamine-receptor agonists. Psychopharmacology51, 293–299 (1977).
Svensson, T. H. The effect of inhibition of catecholamine synthesis on dexamphetamine induced central stimulation. European J. Pharmacol.12, 161–166 (1969). Erratum:13, 139–140 (1970).
Svensson, T. H., Bunney, B. S., Agbahanian, G. K. Inhibition of both noradrenergic and serotonergic neurons in brain by theα-adrenergic agonist clonidine. Brain Res.92, 291–306 (1975).
Svensson, T. H., Waldeck, B. Significance of acetaldehyde in ethanolinduced effects on catecholamine metabolism and motor activity in the mouse. Psychopharmacologia (Berl.)31, 229–238 (1973).
Waldeck, B. Ethanol and coffeine: a complex interaction with respect to locomotor activity and central catecholamines. Psychopharmacologia (Berl.)36, 209–220 (1974).
Vander Wende, C., Spoerlein, M. T., Luc, N. C. Studies on the role of dopaminergic systems in morphine-induced motor activity. Comparison with noradrenergic and cholinergic systems. Res. Commun. Chem. Pathol. Pharmacol.11, 79–88 (1975).
Weissman, A., Koe, B. K., Tenen, S. Antiamphetamine effects following inhibition of tyrosine hydroxylase. J. Pharmacol. exp. Ther.151, 339 to 352 (1966).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Strömbom, U., Svensson, T.H. Antagonism of morphine-induced central stimulation in mice by small doses of catecholamine-receptor agonists. J. Neural Transmission 42, 169–179 (1978). https://doi.org/10.1007/BF01675308
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01675308